Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Overactive Bladder Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Overactive Bladder Treatmentmarket, defines the market attractiveness level of Overactive Bladder Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Overactive Bladder Treatment industry, describes the types of Overactive Bladder Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Overactive Bladder Treatment market and the development prospects and opportunities of Overactive Bladder Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Overactive Bladder Treatment market in Chapter 13.
By Player:
Teva (Activas)
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
By Type:
Anticholinergics
Mirabegron
Botox
By End-User:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Overactive Bladder Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Overactive Bladder Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Overactive Bladder Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Overactive Bladder Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Overactive Bladder Treatment Market Analysis and Outlook to 2022
-
7.1 Global Overactive Bladder Treatment Consumption (2017-2022)
-
7.2 United States Overactive Bladder Treatment Consumption (2017-2022)
-
7.3 Europe Overactive Bladder Treatment Consumption (2017-2022)
-
7.4 China Overactive Bladder Treatment Consumption (2017-2022)
-
7.5 Japan Overactive Bladder Treatment Consumption (2017-2022)
-
7.6 India Overactive Bladder Treatment Consumption (2017-2022)
-
7.7 South Korea Overactive Bladder Treatment Consumption (2017-2022)
8 Region and Country-wise Overactive Bladder Treatment Market Analysis and Outlook to 2028
-
8.1 Global Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.2 United States Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.4 China Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.6 India Overactive Bladder Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Overactive Bladder Treatment Consumption Forecast (2022-2028)
9 Global Overactive Bladder Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Overactive Bladder Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mirabegron Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Botox Consumption and Growth Rate (2017-2022)
-
9.2 Global Overactive Bladder Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Idiopathic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurogenic Overactive Bladder Consumption and Growth Rate (2017-2022)
10 Global Overactive Bladder Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Overactive Bladder Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mirabegron Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Botox Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Overactive Bladder Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Idiopathic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neurogenic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
11 Global Overactive Bladder Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Overactive Bladder Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Overactive Bladder Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Overactive Bladder Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Overactive Bladder Treatment Market Competitive Analysis
-
14.1 Teva (Activas)
-
14.1.1 Teva (Activas) Company Details
-
14.1.2 Teva (Activas) Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Teva (Activas) Overactive Bladder Treatment Product and Service
-
14.2 Allergan
-
14.2.1 Allergan Company Details
-
14.2.2 Allergan Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Allergan Overactive Bladder Treatment Product and Service
-
14.3 Astellas Pharma
-
14.3.1 Astellas Pharma Company Details
-
14.3.2 Astellas Pharma Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astellas Pharma Overactive Bladder Treatment Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Overactive Bladder Treatment Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Overactive Bladder Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Overactive Bladder Treatment
-
Figure Overactive Bladder Treatment Picture
-
Table Global Overactive Bladder Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Overactive Bladder Treatment Consumption by Country (2017-2022)
-
Figure United States Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Overactive Bladder Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Overactive Bladder Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Overactive Bladder Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
Figure Global Mirabegron Consumption and Growth Rate (2017-2022)
-
Figure Global Botox Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
Figure Global Neurogenic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
Figure Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mirabegron Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botox Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurogenic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Overactive Bladder Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Overactive Bladder Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Teva (Activas) (Foundation Year, Company Profile and etc.)
-
Table Teva (Activas) Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva (Activas) Overactive Bladder Treatment Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Overactive Bladder Treatment Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Overactive Bladder Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Overactive Bladder Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Overactive Bladder Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Overactive Bladder Treatment Product and Service
-
